BiotechTube
Home/TrippBio/Richard Still
RS

Richard Still

CFO

TrippBio

Therapeutic Areas

Infectious DiseaseRespiratory

TrippBio Pipeline

DrugIndicationPhase
PanCytoVir™ (oral probenecid)COVID-19Phase 2

Leadership Team at TrippBio

DM
David Martin
CEO
RA
Ralph A. Tripp
Chief Science Officer
BM
Billy Meadow
Chairman of the Board
View full TrippBio profile